Literature DB >> 20402410

The HIV-1 matrix protein p17 activates the transcription factors c-Myc and CREB in human B cells.

Song Li1, Luisa Bozzo, Zhibin Wu, Wuyuan Lu, Fabio Romerio.   

Abstract

The human immunodeficiency virus matrix protein p17 plays a critical role in many steps of the virus life cycle. In addition, p17 displays biological activities outside infected cells. Indeed, virus-neutralizing antibodies against p17 in plasma of infected patients correlate with slower disease progression, and p17 has been shown to interact with an as yet unidentified cell surface receptor expressed on peripheral blood B cells. The present study investigated intracellular signaling pathways triggered following this interaction. Using protein/DNA arrays, we show that p17 increases phosphorylation and the DNA-binding activity of CREB and c-Myc through the time- and dose-dependent activation of the cAMP/PKA and MEK/ERK signaling pathways. Interestingly, we found that both signaling pathways are synergistically activated upon co-stimulation through the CD19 receptor. As both CREB and c-Myc are involved in the regulation of cell proliferation, differentiation, and survival, our findings might suggest a potential mechanism of B cell lymphomagenesis during HIV-1 infection.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20402410

Source DB:  PubMed          Journal:  New Microbiol        ISSN: 1121-7138            Impact factor:   2.479


  2 in total

1.  In the South African setting, HIV-associated Burkitt lymphoma is associated with frequent leukaemic presentation, complex cytogenetic karyotypes, and adverse clinical outcomes.

Authors:  Jessica Opie; Katherine Antel; Ania Koller; Nicolas Novitzky
Journal:  Ann Hematol       Date:  2020-01-18       Impact factor: 3.673

2.  Association of VH4-59 Antibody Variable Gene Usage with Recognition of an Immunodominant Epitope on the HIV-1 Gag Protein.

Authors:  Valentine U Chukwuma; Mark D Hicar; Xuemin Chen; Katherine J Nicholas; Amanda Joyner; Spyros A Kalams; Gary Landucci; Donald N Forthal; Paul W Spearman; James E Crowe
Journal:  PLoS One       Date:  2015-07-30       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.